Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil

BackgroundRobust data comparing long COVID in hospitalized and non-hospitalized patients in middle-income countries are limited.MethodsA retrospective cohort study was conducted in Brazil, including hospitalized and non-hospitalized patients. Long COVID was diagnosed at 90-day follow-up using WHO cr...

Full description

Bibliographic Details
Main Authors: Daniel Tavares Malheiro, Sabrina Bernardez-Pereira, Kauê Capellato Junqueira Parreira, João Gabriel Dias Pagliuso, Emerson de Paula Gomes, Daisa de Mesquita Escobosa, Carolina Ivo de Araújo, Beatriz Silva Pimenta, Vivian Lin, Silvana Maria de Almeida, Paula Tuma, Claudia Regina Laselva, Miguel Cendoroglo Neto, Sidney Klajner, Vanessa Damazio Teich, Takaaki Kobayashi, Michael B. Edmond, Alexandre R. Marra
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1302669/full
_version_ 1827376874445078528
author Daniel Tavares Malheiro
Sabrina Bernardez-Pereira
Kauê Capellato Junqueira Parreira
João Gabriel Dias Pagliuso
Emerson de Paula Gomes
Daisa de Mesquita Escobosa
Carolina Ivo de Araújo
Beatriz Silva Pimenta
Vivian Lin
Silvana Maria de Almeida
Paula Tuma
Claudia Regina Laselva
Miguel Cendoroglo Neto
Sidney Klajner
Vanessa Damazio Teich
Takaaki Kobayashi
Michael B. Edmond
Alexandre R. Marra
Alexandre R. Marra
author_facet Daniel Tavares Malheiro
Sabrina Bernardez-Pereira
Kauê Capellato Junqueira Parreira
João Gabriel Dias Pagliuso
Emerson de Paula Gomes
Daisa de Mesquita Escobosa
Carolina Ivo de Araújo
Beatriz Silva Pimenta
Vivian Lin
Silvana Maria de Almeida
Paula Tuma
Claudia Regina Laselva
Miguel Cendoroglo Neto
Sidney Klajner
Vanessa Damazio Teich
Takaaki Kobayashi
Michael B. Edmond
Alexandre R. Marra
Alexandre R. Marra
author_sort Daniel Tavares Malheiro
collection DOAJ
description BackgroundRobust data comparing long COVID in hospitalized and non-hospitalized patients in middle-income countries are limited.MethodsA retrospective cohort study was conducted in Brazil, including hospitalized and non-hospitalized patients. Long COVID was diagnosed at 90-day follow-up using WHO criteria. Demographic and clinical information, including the depression screening scale (PHQ-2) at day 30, was compared between the groups. If the PHQ-2 score is 3 or greater, major depressive disorder is likely. Logistic regression analysis identified predictors and protective factors for long COVID.ResultsA total of 291 hospitalized and 1,118 non-hospitalized patients with COVID-19 were included. The prevalence of long COVID was 47.1% and 49.5%, respectively. Multivariable logistic regression showed female sex (odds ratio [OR] = 4.50, 95% confidence interval (CI) 2.51–8.37), hypertension (OR = 2.90, 95% CI 1.52–5.69), PHQ-2 > 3 (OR = 6.50, 95% CI 1.68–33.4) and corticosteroid use during hospital stay (OR = 2.43, 95% CI 1.20–5.04) as predictors of long COVID in hospitalized patients, while female sex (OR = 2.52, 95% CI 1.95–3.27) and PHQ-2 > 3 (OR = 3.88, 95% CI 2.52–6.16) were predictors in non-hospitalized patients.ConclusionLong COVID was prevalent in both groups. Positive depression screening at day 30 post-infection can predict long COVID. Early screening of depression helps health staff to identify patients at a higher risk of long COVID, allowing an early diagnosis of the condition.
first_indexed 2024-03-08T12:30:10Z
format Article
id doaj.art-5fbca8e13039468ab8563d054c5ac269
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-03-08T12:30:10Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-5fbca8e13039468ab8563d054c5ac2692024-01-22T04:20:04ZengFrontiers Media S.A.Frontiers in Public Health2296-25652024-01-011110.3389/fpubh.2023.13026691302669Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, BrazilDaniel Tavares Malheiro0Sabrina Bernardez-Pereira1Kauê Capellato Junqueira Parreira2João Gabriel Dias Pagliuso3Emerson de Paula Gomes4Daisa de Mesquita Escobosa5Carolina Ivo de Araújo6Beatriz Silva Pimenta7Vivian Lin8Silvana Maria de Almeida9Paula Tuma10Claudia Regina Laselva11Miguel Cendoroglo Neto12Sidney Klajner13Vanessa Damazio Teich14Takaaki Kobayashi15Michael B. Edmond16Alexandre R. Marra17Alexandre R. Marra18Hospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, BrazilDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United StatesWest Virginia University School of Medicine, Morgantown, WV, United StatesHospital Israelita Albert Einstein, São Paulo, BrazilDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United StatesBackgroundRobust data comparing long COVID in hospitalized and non-hospitalized patients in middle-income countries are limited.MethodsA retrospective cohort study was conducted in Brazil, including hospitalized and non-hospitalized patients. Long COVID was diagnosed at 90-day follow-up using WHO criteria. Demographic and clinical information, including the depression screening scale (PHQ-2) at day 30, was compared between the groups. If the PHQ-2 score is 3 or greater, major depressive disorder is likely. Logistic regression analysis identified predictors and protective factors for long COVID.ResultsA total of 291 hospitalized and 1,118 non-hospitalized patients with COVID-19 were included. The prevalence of long COVID was 47.1% and 49.5%, respectively. Multivariable logistic regression showed female sex (odds ratio [OR] = 4.50, 95% confidence interval (CI) 2.51–8.37), hypertension (OR = 2.90, 95% CI 1.52–5.69), PHQ-2 > 3 (OR = 6.50, 95% CI 1.68–33.4) and corticosteroid use during hospital stay (OR = 2.43, 95% CI 1.20–5.04) as predictors of long COVID in hospitalized patients, while female sex (OR = 2.52, 95% CI 1.95–3.27) and PHQ-2 > 3 (OR = 3.88, 95% CI 2.52–6.16) were predictors in non-hospitalized patients.ConclusionLong COVID was prevalent in both groups. Positive depression screening at day 30 post-infection can predict long COVID. Early screening of depression helps health staff to identify patients at a higher risk of long COVID, allowing an early diagnosis of the condition.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1302669/fulllong COVIDmental healthdepression screeningquality of lifemiddle income countries
spellingShingle Daniel Tavares Malheiro
Sabrina Bernardez-Pereira
Kauê Capellato Junqueira Parreira
João Gabriel Dias Pagliuso
Emerson de Paula Gomes
Daisa de Mesquita Escobosa
Carolina Ivo de Araújo
Beatriz Silva Pimenta
Vivian Lin
Silvana Maria de Almeida
Paula Tuma
Claudia Regina Laselva
Miguel Cendoroglo Neto
Sidney Klajner
Vanessa Damazio Teich
Takaaki Kobayashi
Michael B. Edmond
Alexandre R. Marra
Alexandre R. Marra
Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil
Frontiers in Public Health
long COVID
mental health
depression screening
quality of life
middle income countries
title Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil
title_full Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil
title_fullStr Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil
title_full_unstemmed Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil
title_short Prevalence, predictors, and patient-reported outcomes of long COVID in hospitalized and non-hospitalized patients from the city of São Paulo, Brazil
title_sort prevalence predictors and patient reported outcomes of long covid in hospitalized and non hospitalized patients from the city of sao paulo brazil
topic long COVID
mental health
depression screening
quality of life
middle income countries
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1302669/full
work_keys_str_mv AT danieltavaresmalheiro prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT sabrinabernardezpereira prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT kauecapellatojunqueiraparreira prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT joaogabrieldiaspagliuso prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT emersondepaulagomes prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT daisademesquitaescobosa prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT carolinaivodearaujo prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT beatrizsilvapimenta prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT vivianlin prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT silvanamariadealmeida prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT paulatuma prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT claudiareginalaselva prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT miguelcendorogloneto prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT sidneyklajner prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT vanessadamazioteich prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT takaakikobayashi prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT michaelbedmond prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT alexandrermarra prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil
AT alexandrermarra prevalencepredictorsandpatientreportedoutcomesoflongcovidinhospitalizedandnonhospitalizedpatientsfromthecityofsaopaulobrazil